Compare QTTB & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTTB | CULP |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.3M | 43.8M |
| IPO Year | 2018 | 1994 |
| Metric | QTTB | CULP |
|---|---|---|
| Price | $6.37 | $2.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 349.4K | 38.4K |
| Earning Date | 05-07-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 136.78 | N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | $53,737,000.00 | ★ $213,237,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.42 |
| P/E Ratio | $2.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.38 | $2.70 |
| 52 Week High | $8.05 | $4.75 |
| Indicator | QTTB | CULP |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 28.25 |
| Support Level | $3.49 | N/A |
| Resistance Level | $7.80 | $3.60 |
| Average True Range (ATR) | 0.93 | 0.17 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 34.32 | 2.17 |
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.